Emergent BioSolutions Inc. (EBS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 100M 200M 300M Q3 '24: 293.8M Q4 '24: 194.7M Q1 '25: 222.2M Q2 '25: 140.9M Q3 '25: 231.1M Q4 '25: 148.7M Q1 '26: 156.1M Q2 '26: 234.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-60M 0 60M 120M 180M Q4 '22: 102.6M Q1 '23: 4.9M Q2 '23: 140.7M Q3 '23: 87.2M Q4 '23: 84.8M Q1 '24: 147.8M Q2 '24: -48M Q3 '24: 161.2M Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24

Operating Income Quarterly

-210M -140M -70M 0 70M 140M 210M Q2 '24: -203.5M Q3 '24: 64.5M Q4 '24: -9.5M Q1 '25: 49.9M Q2 '25: 1.6M Q3 '25: 76.5M Q1 '26: 10.5M Q2 '26: -125.1M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Net Income Quarterly

-210M -140M -70M 0 70M 140M 210M Q3 '24: 114.8M Q4 '24: -31.3M Q1 '25: 68M Q2 '25: -12M Q3 '25: 51.2M Q4 '25: -54.6M Q1 '26: 6.8M Q2 '26: -180.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 50M 100M 150M Q3 '24: 122.6M Q4 '24: 118M Q1 '25: 88.5M Q2 '25: 66.9M Q3 '25: 85.9M Q4 '25: 84.9M Q1 '26: 72M Q2 '26: 97.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-120M -60M 0 60M 120M 180M Q3 '24: 153.7M Q4 '24: -79.9M Q1 '25: -11.2M Q2 '25: 106.4M Q3 '25: -2.3M Q4 '25: 77.7M Q1 '26: -33.8M Q2 '26: 56.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-120M -60M 0 60M 120M 180M Q3 '24: 147.9M Q4 '24: -81.6M Q1 '25: -14.8M Q2 '25: 103.5M Q3 '25: -5.7M Q4 '25: 73.8M Q1 '26: -36.2M Q2 '26: 54M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 52.2M Q2 '24: 52.6M Q3 '24: 55.6M Q1 '25: 57.3M Q2 '25: 54.2M Q3 '25: 56.5M Q1 '26: 56.5M Q2 '26: 51.6M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '24: -4.03 Q4 '24: -3.60 Q1 '25: -2.58 Q2 '25: 2.58 Q3 '25: 1.43 Q4 '25: 0.93 Q1 '26: -0.19 Q2 '26: -3.46 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.